Venus Acquisition (VENAW) Competitors $0.05 0.00 (0.00%) As of 07/11/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock VENAW vs. DOCS, TSRI, STIX, RCRT, VENA, EVOL, SBIG, and DMNShould you be buying Venus Acquisition stock or one of its competitors? The main competitors of Venus Acquisition include Doximity (DOCS), TSR (TSRI), Semantix (STIX), Recruiter.com Group (RCRT), Venus Acquisition (VENA), Symbolic Logic (EVOL), SpringBig (SBIG), and Grafiti (DMN). Venus Acquisition vs. Its Competitors Doximity TSR Semantix Recruiter.com Group Venus Acquisition Symbolic Logic SpringBig Grafiti Venus Acquisition (NASDAQ:VENAW) and Doximity (NASDAQ:DOCS) are both custom computer programming services industry companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, earnings, profitability, dividends, risk, analyst recommendations and institutional ownership. Is VENAW or DOCS more profitable? Doximity has a net margin of 36.60% compared to Venus Acquisition's net margin of 0.00%. Doximity's return on equity of 21.75% beat Venus Acquisition's return on equity.Company Net Margins Return on Equity Return on Assets Venus AcquisitionN/A N/A N/A Doximity 36.60%21.75%18.64% Do institutionals & insiders have more ownership in VENAW or DOCS? 87.2% of Doximity shares are held by institutional investors. 37.4% of Doximity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Do analysts recommend VENAW or DOCS? Doximity has a consensus target price of $64.89, indicating a potential upside of 6.58%. Given Doximity's stronger consensus rating and higher probable upside, analysts plainly believe Doximity is more favorable than Venus Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Venus Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Doximity 0 Sell rating(s) 10 Hold rating(s) 10 Buy rating(s) 2 Strong Buy rating(s) 2.64 Which has higher valuation & earnings, VENAW or DOCS? Doximity has higher revenue and earnings than Venus Acquisition. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVenus AcquisitionN/AN/AN/AN/AN/ADoximity$570.40M20.05$147.58M$1.1154.86 Does the media refer more to VENAW or DOCS? In the previous week, Doximity had 24 more articles in the media than Venus Acquisition. MarketBeat recorded 24 mentions for Doximity and 0 mentions for Venus Acquisition. Doximity's average media sentiment score of 0.83 beat Venus Acquisition's score of 0.00 indicating that Doximity is being referred to more favorably in the news media. Company Overall Sentiment Venus Acquisition Neutral Doximity Positive SummaryDoximity beats Venus Acquisition on 12 of the 12 factors compared between the two stocks. Get Venus Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for VENAW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VENAW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VENAW vs. The Competition Export to ExcelMetricVenus AcquisitionCustom Computer Programming Services Industry SectorNASDAQ ExchangeMarket CapN/A$1.65B$2.02B$9.40BDividend YieldN/AN/A13.73%4.05%P/E RatioN/A7.5912.3319.84Price / SalesN/A4.132,696,702.55100.72Price / CashN/A34.9957.5257.94Price / BookN/A3.563.235.64Net IncomeN/A$15.21M-$461.08M$257.97M7 Day PerformanceN/A-1.75%0.49%2.12%1 Month PerformanceN/A1.14%2.89%11.21%1 Year PerformanceN/A-3.69%6.40%18.36% Venus Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VENAWVenus AcquisitionN/A$0.05flatN/AN/A$0.00N/A0.00N/ADOCSDoximity2.6978 of 5 stars$61.47+2.1%$64.42+4.8%+112.5%$11.54B$570.40M61.47890News CoveragePositive NewsAnalyst ForecastTSRITSRN/A$13.38flatN/AN/A$29.04M$88.82M15.74630STIXSemantixN/AN/AN/AN/A$23.73M$264.23M0.004RCRTRecruiter.com GroupN/A$2.22+2.8%N/A+1.0%$6.00M$716.53K0.00140High Trading VolumeVENAVenus AcquisitionN/A$0.74+3.7%N/A-77.2%$4.51MN/A0.00125Gap UpHigh Trading VolumeEVOLSymbolic LogicN/A$0.41flatN/AN/A$4.44MN/A0.008SBIGSpringBigN/A$0.05+2.2%$1.00+1,876.3%-69.3%$2.35M$28.37M-0.63160DMNGrafitiN/A$0.11+22.2%N/AN/A$508K$386.09K0.00N/AGap Down Related Companies and Tools Related Companies DOCS Competitors TSRI Competitors STIX Competitors RCRT Competitors VENA Competitors EVOL Competitors SBIG Competitors DMN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VENAW) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredNew crypto laws coming. Will you win or lose?Washington’s first-ever “Crypto Week” could trigger a major Bitcoin surge — but one trader says don’t just buy...Brownstone Research | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | Sponsored"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the sa...Crypto 101 Media | SponsoredWill I be blacklisted?Porter Stansberry says a financial force bigger than 9/11 or COVID is already ripping through America — and mo...Porter & Company | Sponsored“All the land that you see I will give to you and your offspring forever…”“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMiss This Window And You Miss EverythingThere’s a moment in every crypto cycle when everything just clicks — and that moment is now. This is the ph...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Venus Acquisition Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Venus Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
